Wolfram Syndrome and WFS1-related Disorders International Registry and Clinical Study (NCT02841553) | Clinical Trial Compass
RecruitingNot Applicable
Wolfram Syndrome and WFS1-related Disorders International Registry and Clinical Study
United States5,000 participantsStarted 2011-07
Plain-language summary
In this study, the investigators hypothesize that studying monogenic variants with strong effect associated with severe insulin deficiency of Wolfram syndrome will provide important insights into the more complex type 1 and type 2 diabetes mellitus.
Aim 1. Establish and maintain a registry of patients with Wolfram syndrome. An Internet based registry will be employed to enroll participants with the clinical diagnosis of Wolfram syndrome (insulin dependent DM and bilateral OA). Clinical information regarding age of diagnosis and progression of the disease will be collated and analyzed to better define its natural history, along with potential metabolic phenotypes such as glucose intolerance of heterozygous parents and unaffected sibs.
If not already completed, blood for WFS1 sequence analysis will be obtained on the participants (parents and sibs also for control purposes) and sent to a CLIA certified lab to define the mutation. This information will benefit patient families and referring physicians by providing a genetic diagnosis and where indicated. The Wolfram Syndrome Registry will foster international collaborations to more efficiently and systematically collect Wolfram syndrome patients and their clinical and experimental data.
Who can participate
Age range
0 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Any patient worldwide with a diagnosis of Wolfram syndrome and with access to the Internet can be enrolled in the Registry. Since the disease usually manifests in the first decade of life and tends to have an inevitably progressive course, participation of minors is important for establishing the natural course of the disease.
Inclusion Criteria:
Major Criteria
* Diabetes mellitus \<16 yrs
* Optic atrophy \<16 yrs
Minor Criteria
* Diabetes insipidus
* Diabetes mellitus \>16yrs
* Optic atrophy \>16 yrs
* Sensorineural deafness
* Neurological signs (ataxia, epilepsy, cognitive impairment)
* Renal tract abnormalities (structural or functional)
* 1 loss of function mutation in WFS1/CISD2 AND/OR family history of Wolfram syndrome
Minimum Required
* 2 major OR
* 1 major plus 2 minor criteria OR
* 2 pathological WFS1 or CISD2 mutations are identified
Other variable suggestive evidence
* Hypogonadism (males)
* An absence of type 1 diabetes auto-antibodies
* Bilateral cataracts
* Psychiatric disorder
* Gastrointestinal
Exclusion Criteria:
Inability of a patient and/or a guardian to obtain help with translation and thus, inability to understand questionnaire.
Parent, Sibs, and Spouses:
\- Parents, sibs, and spouses that are unaffected will be recruited as controls. Inclusion criterion is having the unaffected status and exclusion criterion is if the person cannot understand the Informed Consent Document.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.